BMO Capital Markets reiterated its Outperform rating and $222.00 price target for Allstate Corporation (NYSE:ALL), expressing ...

BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) stock, maintaining both their Outperform rating and a $105.00 price target. The endorsement comes in the wake of promising ...

Canadian bank's capital markets arm reportedly failed to detect representatives' misleading disclosures involving $3 billion ...

BMO Capital Markets agreed to pay more than $40 million to settle U.S. Securities and Exchange Commission charges it failed ...

A unit of Bank of Montreal agreed to pay $40.7 million to settle U.S. Securities and Exchange Commission charges that it ...

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $34.13 which represents a slight increase of $1.25 or 3.80% from the prior close of $32.88. The stock opened at $33 and touched a low ...

While the bank did not admit or deny any wrongdoing, BMO accepted a formal censure from the SEC as part of the settlement ...

Ionis Pharmaceuticals Inc (IONS) stock saw a modest uptick, ending the day at $34.46 which represents a slight increase of $1.96 or 6.03% from the prior close of $32.5. The stock opened at $32.58 and ...

The online poll also found 48 per cent of those surveyed believed the economy will weaken over the next year, while 19 per ...

BMO Capital raised the firm’s price target on Vistra (VST) to $191 from $151 and keeps an Outperform rating on the shares. The impact of the ...

BMO Capital says Belarusian potash supplier Belaruskali is cutting 1 metric ton of potash production in the first half of 2025 for efficiency ...